FinTrust Capital Advisors’s CareDx CDNA Stock Holding History
Bought
Maintained
Sold
Other funds holding CDNA
AIM
ACH
BG
NAMA
GS
FinTrust Capital Advisors's CDNA Position: Q4 2022 in Review
FinTrust Capital Advisors sold out of CareDx (CDNA) in Q4 2022, closing a stake of 57 shares — an estimated $1K sold.
FinTrust Capital Advisors first reported a position in CDNA in Q4 2018 and held it in 16 quarters. The position peaked at $33K in Q4 2020. 168 funds tracked by Wall St. Rank hold CDNA as of Q4 2022.
- FinTrust Capital Advisors reported no remaining CareDx position as of Q4 2022 after selling out during the quarter.
- FinTrust Capital Advisors sold 57 CareDx shares in Q4 2022, an estimated $1K.
- FinTrust Capital Advisors first reported a position in CareDx in Q4 2018 and held it in 16 quarters.
- FinTrust Capital Advisors's CareDx position peaked at $33K in Q4 2020.
- 168 funds tracked by Wall St. Rank held CareDx as of Q4 2022.
Based on FinTrust Capital Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.